Key facts
- Camber Capital Management LP filed SCHEDULE 13G/A for PTC THERAPEUTICS, INC. Common Stock $0.001 par value per share (PTCT).
- Disclosed ownership: 4.2%.
- Date of event: 31 Dec 2024.
Camber Capital Management LP - 31 Dec 2024 SCHEDULE 13G/A Report for PTC THERAPEUTICS, INC. Common Stock $0.001 par value per share (PTCT)
- Filing Manager
- Camber Capital Management LP
- Reporting Manager
- Camber Capital Management LP
- Symbol
- PTCT
- Shares outstanding
- 77,108,434 shares
- Disclosed Ownership
- 3,200,000 shares
- Ownership
- 4.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 08:35:58 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Key filing fact
Camber Capital Management LP disclosed 4.2% ownership in PTC THERAPEUTICS, INC. Common Stock $0.001 par value per share (PTCT) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 08:35.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Camber Capital Management LP | 4.2% | 3,200,000 | 0 | 3,200,000 | /s/ Sean George | Sean George, Chief Financial Officer | |
| Stephen DuBois | 4.2% | 3,200,000 | 0 | 3,200,000 | /s/ Sean George | Sean George, Chief Financial Officer |
CIK / CUSIP context first